DR

David D. Roberts

US US Dept of Health & Human Services: 11 patents #41 of 3,044Top 2%
WU Washington University: 2 patents #386 of 1,596Top 25%
TF The Uab Research Foundation: 1 patents #374 of 813Top 50%
📍 Bethesda, MD: #29 of 2,269 inventorsTop 2%
🗺 Maryland: #524 of 35,612 inventorsTop 2%
Overall (All Time): #112,261 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 1–25 of 32 patents

Patent #TitleCo-InventorsDate
11692175 Methods for generation of pluripotent and multipotent cells Sukhbir Kaur, Jeffrey S. Isenberg 2023-07-04
11285169 Methods for modulating chemotherapeutic cytotoxicity David R. Soto Pantoja 2022-03-29
11254735 Prevention of tissue ischemia and related methods Jeffrey S. Isenberg, William A. Frazier 2022-02-22
11053314 Methods to eliminate cancer stem cells by targeting CD47 Sukhbir Kaur, Chengyu Liu 2021-07-06
10407665 Methods for generation of pluripotent and multipotent cells Sukhbir Kaur, Jeffrey S. Isenberg 2019-09-10
10370439 Prevention of tissue ischemia and related methods Jeffrey S. Isenberg 2019-08-06
8951527 Radioprotectants targeting thrombospondin-1 and CD47 Jeffrey S. Isenberg, Justin Maxhimer 2015-02-10
8865672 Prevention of tissue ischemia and related methods Jeffrey S. Isenberg 2014-10-21
8794272 Granular filler transfer device Karen L. Foley 2014-08-05
8557788 Prevention of tissue ischemia and related compositions Jeffrey S. Isenberg 2013-10-15
8344019 Methods for the production of biliverdin MICHAEL L. PENDRAK 2013-01-01
8236313 Prevention of tissue ischemia, related methods and compositions Jeffrey S. Isenberg, William A. Frazier 2012-08-07
8114406 Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins Henry C. Krutzsch 2012-02-14
7745144 Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins Henry C. Krutzsch 2010-06-29
7618789 Use of semenogelin in the diagnosis, prognosis and treatment of cancer Henry C. Krutzsch 2009-11-17
7504243 Methods for the production of biliverdin MICHAEL L. PENDRAK 2009-03-17
7332167 Nucleic acid and amino acid sequences of hemoglobin-response genes in Candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated Candida albicans infection Sizhuang (Steve) Yan 2008-02-19
7129052 Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins Henry C. Krutzsch 2006-10-31
6875855 NUCLEIC ACID AND AMINO ACID SEQUENCES OF HEMOGLOBIN-RESPONSE GENES IN CANDIDA ALBICANS AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN THE DIAGNOSIS OF DISSEMINATED CANDIDA ALBICANS INFECTION Sizhuang Steve Yan 2005-04-05
6458767 Use of peptides inhibitory for thrombospondin dependent TGF-&bgr; activation in the treatment of kidney disease Joanne Murphy-Ullrich, Solange M. F. Ribeiro, Christian Hugo, Henry C. Krutzsch 2002-10-01
6384189 Compositions for stimulating TGF-&bgr; activity Joanne Murphy-Ullrich, Stacey L. Schultz-Cherry, Henry C. Krutzsch 2002-05-07
6051549 Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof Henry C. Krutzsch, Nenghua Guo 2000-04-18
5849701 Peptide inhibitors of fibronectin and related collagen-binding proteins Henry C. Krutzsch, John M. Sipes, Neng Guo, Eric Negre 1998-12-15
5770563 Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof Philip J. Browning, Joseph Bryant, John K. Inman, Henry C. Krutzsch, Nenghua Guo 1998-06-23
5529904 Diagnostic kit and diagnostic method for mycoplasma utilizing carbohydrate receptors Victor Ginsburg, Howard C. Krivan 1996-06-25